Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Cutis ; 80(1): 42-4, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17725063

RESUMO

Blue nevi can present clinically as blue, gray, brown, or black solitary nodules or plaques on the skin. Histologically, they represent collections of melanocytes and melanophages in the dermis. We present a case of a cellular blue nevus in a 55-year-old white man that presented as an enlarging blue-gray nodule on the right dorsal foot. These cases can be challenging both clinically and histologically because malignant melanoma or malignant transformation of a blue nevus should be considered. We review the various types of blue nevi and the literature.


Assuntos
Nevo Azul/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Nevo Azul/cirurgia
2.
Cutis ; 80(4): 289-94, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18038690

RESUMO

Pancreatic panniculitis represents a rare skin manifestation of underlying pancreatic pathology. The clinical presentation of the condition is remarkably consistent and privy to several unique clinical and histopathologic findings. We report a case of a 50-year-old white woman with pancreatic panniculitis and newly diagnosed pancreatic acinic cell adenocarcinoma. The clinical and histopathologic features, underlying causes, and treatments are reviewed.


Assuntos
Adenocarcinoma/complicações , Neoplasias Pancreáticas/complicações , Paniculite/etiologia , Adenocarcinoma/patologia , Adenocarcinoma/terapia , Feminino , Humanos , Pessoa de Meia-Idade , Neoplasias Pancreáticas/patologia , Neoplasias Pancreáticas/terapia , Paniculite/patologia , Paniculite/terapia
3.
Arch Dermatol ; 146(2): 159-63, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20157026

RESUMO

BACKGROUND: Botulinum toxin type A (BTX) is used prophylactically to reduce the frequency of migraine headaches, with inconsistent responses reported in the literature. The purpose of our study was to determine whether BTX injections at doses used for upper-face cosmetic purposes, which differ from doses typically used by headache specialists, could prevent imploding and ocular but not exploding migraines. OBSERVATIONS: Study participants were recruited among patients who had received or were planning to receive BTX injections for upper-face cosmetic purposes but also reported having migraines. Among the 18 patients who completed the study, most with imploding and ocular migraines experienced a significant reduction in their headache frequency, whereas those with exploding migraines generally did not. CONCLUSIONS: Our study supports the hypothesis that patients with imploding and ocular migraines are more responsive to BTX than those with exploding migraines. Injections of BTX at doses appropriate for cosmetic purposes may be sufficient to prevent migraine attacks.


Assuntos
Toxinas Botulínicas Tipo A/administração & dosagem , Transtornos de Enxaqueca/prevenção & controle , Fármacos Neuromusculares/administração & dosagem , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Coortes , Técnicas Cosméticas , Relação Dose-Resposta a Droga , Face , Feminino , Humanos , Injeções Intramusculares , Masculino , Pessoa de Meia-Idade , Transtornos de Enxaqueca/complicações , Transtornos de Enxaqueca/diagnóstico , Resultado do Tratamento , Adulto Jovem
4.
Pediatr Dermatol ; 23(4): 342-5, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16918629

RESUMO

Prune-belly syndrome is a congenital disorder characterized by abdominal wall musculature deficiency, urinary tract anomalies, and bilateral cryptorchidism. Because of the defect in the musculature, the abdominal skin has a peculiar wrinkled appearance. The syndrome is commonly associated with pulmonary, skeletal, cardiac, and gastrointestinal defects. Developmental delays and growth retardation have also been reported. The incidence of prune belly syndrome is approximately 1:40,000 live births. Over 95% of patients are men. Urinary tract disease is the major prognostic factor, with the complications of pulmonary hypoplasia and end stage renal disease resulting in a mortality rate of 60%. Treatment involves surgical correction of the abdominal wall defect and urinary tract abnormalities, early orchiopexy, and supportive management of associated defects.


Assuntos
Síndrome do Abdome em Ameixa Seca/diagnóstico , Anormalidades da Pele/diagnóstico , Parede Abdominal/cirurgia , Adolescente , Feminino , Humanos , Lactente , Deficiência Intelectual/etiologia , Masculino , Síndrome do Abdome em Ameixa Seca/epidemiologia , Síndrome do Abdome em Ameixa Seca/psicologia , Síndrome do Abdome em Ameixa Seca/cirurgia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA